nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyamemazine—HTR2A—coronary artery disease	0.725	1	CbGaD
Cyamemazine—HTR2A—arteriole—coronary artery disease	0.0161	0.201	CbGeAlD
Cyamemazine—HTR2A—pulmonary artery—coronary artery disease	0.0105	0.132	CbGeAlD
Cyamemazine—HTR2A—sympathetic nervous system—coronary artery disease	0.0102	0.128	CbGeAlD
Cyamemazine—HTR2A—vagus nerve—coronary artery disease	0.00992	0.124	CbGeAlD
Cyamemazine—HTR2A—vein—coronary artery disease	0.00959	0.12	CbGeAlD
Cyamemazine—HTR2A—autonomic nervous system—coronary artery disease	0.00689	0.086	CbGeAlD
Cyamemazine—HTR2A—artery—coronary artery disease	0.0039	0.0488	CbGeAlD
Cyamemazine—HTR2A—endothelium—coronary artery disease	0.0033	0.0412	CbGeAlD
Cyamemazine—CHRM2—heart—coronary artery disease	0.00297	0.0371	CbGeAlD
Cyamemazine—CHRM2—cardiovascular system—coronary artery disease	0.00281	0.035	CbGeAlD
Cyamemazine—HTR2A—heart—coronary artery disease	0.00144	0.018	CbGeAlD
Cyamemazine—HTR2A—cardiovascular system—coronary artery disease	0.00136	0.0169	CbGeAlD
Cyamemazine—HTR2A—blood—coronary artery disease	0.00107	0.0134	CbGeAlD
Cyamemazine—Clomipramine—HRH2—coronary artery disease	0.001	0.124	CrCbGaD
Cyamemazine—Clomipramine—GSTP1—coronary artery disease	0.000415	0.0514	CrCbGaD
Cyamemazine—Imipramine—SLC22A3—coronary artery disease	0.000366	0.0452	CrCbGaD
Cyamemazine—Diltiazem—CYP2C19—coronary artery disease	0.000337	0.0416	CrCbGaD
Cyamemazine—Thioridazine—HTR7—coronary artery disease	0.00032	0.0397	CrCbGaD
Cyamemazine—Perphenazine—HTR7—coronary artery disease	0.000294	0.0364	CrCbGaD
Cyamemazine—Pipotiazine—CYP2C19—coronary artery disease	0.000267	0.033	CrCbGaD
Cyamemazine—Chlorpromazine—HTR7—coronary artery disease	0.000233	0.0289	CrCbGaD
Cyamemazine—Imipramine—HTR7—coronary artery disease	0.000232	0.0287	CrCbGaD
Cyamemazine—Acepromazine—HTR2A—coronary artery disease	0.000225	0.0278	CrCbGaD
Cyamemazine—Thioproperazine—HTR2A—coronary artery disease	0.00022	0.0272	CrCbGaD
Cyamemazine—Pipotiazine—HTR2A—coronary artery disease	0.000216	0.0268	CrCbGaD
Cyamemazine—Mesoridazine—HTR2A—coronary artery disease	0.000214	0.0264	CrCbGaD
Cyamemazine—Clomipramine—CYP2C19—coronary artery disease	0.000211	0.0261	CrCbGaD
Cyamemazine—Thioridazine—CYP2C19—coronary artery disease	0.000199	0.0246	CrCbGaD
Cyamemazine—Trimipramine—CYP2C19—coronary artery disease	0.000194	0.024	CrCbGaD
Cyamemazine—Fluphenazine—HTR2A—coronary artery disease	0.000187	0.0231	CrCbGaD
Cyamemazine—Perphenazine—CYP2C19—coronary artery disease	0.000182	0.0226	CrCbGaD
Cyamemazine—Propiomazine—HTR2A—coronary artery disease	0.00018	0.0223	CrCbGaD
Cyamemazine—Clomipramine—HTR2A—coronary artery disease	0.000171	0.0212	CrCbGaD
Cyamemazine—Chlorprothixene—HTR2A—coronary artery disease	0.00017	0.0211	CrCbGaD
Cyamemazine—Promazine—CYP2C19—coronary artery disease	0.000164	0.0203	CrCbGaD
Cyamemazine—Thioridazine—HTR2A—coronary artery disease	0.000161	0.0199	CrCbGaD
Cyamemazine—Trimipramine—HTR2A—coronary artery disease	0.000157	0.0195	CrCbGaD
Cyamemazine—Acepromazine—ALB—coronary artery disease	0.000154	0.0191	CrCbGaD
Cyamemazine—Methotrimeprazine—HTR2A—coronary artery disease	0.000154	0.019	CrCbGaD
Cyamemazine—Promethazine—HTR2A—coronary artery disease	0.000152	0.0187	CrCbGaD
Cyamemazine—Thioproperazine—ALB—coronary artery disease	0.00015	0.0186	CrCbGaD
Cyamemazine—Trifluoperazine—HTR2A—coronary artery disease	0.000149	0.0185	CrCbGaD
Cyamemazine—Pipotiazine—ALB—coronary artery disease	0.000148	0.0183	CrCbGaD
Cyamemazine—Perphenazine—HTR2A—coronary artery disease	0.000148	0.0183	CrCbGaD
Cyamemazine—Imipramine—CYP2C19—coronary artery disease	0.000144	0.0178	CrCbGaD
Cyamemazine—Promazine—HTR2A—coronary artery disease	0.000133	0.0165	CrCbGaD
Cyamemazine—Chlorpromazine—HTR2A—coronary artery disease	0.000117	0.0145	CrCbGaD
Cyamemazine—Clomipramine—ALB—coronary artery disease	0.000117	0.0145	CrCbGaD
Cyamemazine—Imipramine—HTR2A—coronary artery disease	0.000117	0.0144	CrCbGaD
Cyamemazine—Chlorpromazine—ALB—coronary artery disease	8.03e-05	0.00993	CrCbGaD
Cyamemazine—HTR2A—Signaling by GPCR—AGT—coronary artery disease	3.1e-05	0.000166	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—F2—coronary artery disease	3.1e-05	0.000166	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—EDNRA—coronary artery disease	3.06e-05	0.000164	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CYBA—coronary artery disease	3.05e-05	0.000163	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ADRB1—coronary artery disease	3.05e-05	0.000163	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—AGT—coronary artery disease	3.05e-05	0.000163	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—DUSP6—coronary artery disease	3.04e-05	0.000162	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ITGAV—coronary artery disease	3.03e-05	0.000162	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—KNG1—coronary artery disease	3.02e-05	0.000161	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—EDNRA—coronary artery disease	3.01e-05	0.000161	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—POMC—coronary artery disease	3.01e-05	0.000161	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CREB1—coronary artery disease	3.01e-05	0.000161	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—AGTR1—coronary artery disease	3e-05	0.00016	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CYBA—coronary artery disease	3e-05	0.00016	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ADRB1—coronary artery disease	3e-05	0.00016	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PLAT—coronary artery disease	2.99e-05	0.000159	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—DUSP6—coronary artery disease	2.98e-05	0.000159	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CCL2—coronary artery disease	2.94e-05	0.000157	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—IL6R—coronary artery disease	2.93e-05	0.000157	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CXCL10—coronary artery disease	2.93e-05	0.000157	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PLAT—coronary artery disease	2.93e-05	0.000157	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PLG—coronary artery disease	2.92e-05	0.000156	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—BDKRB2—coronary artery disease	2.88e-05	0.000154	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CXCL12—coronary artery disease	2.88e-05	0.000154	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—POMC—coronary artery disease	2.88e-05	0.000154	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—F2—coronary artery disease	2.87e-05	0.000153	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—IL6ST—coronary artery disease	2.86e-05	0.000153	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ADRB2—coronary artery disease	2.85e-05	0.000152	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CXCL12—coronary artery disease	2.83e-05	0.000151	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—BDKRB2—coronary artery disease	2.83e-05	0.000151	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—JUNB—coronary artery disease	2.83e-05	0.000151	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—POMC—coronary artery disease	2.82e-05	0.000151	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PLCB1—coronary artery disease	2.82e-05	0.00015	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—F2—coronary artery disease	2.82e-05	0.00015	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PRKCE—coronary artery disease	2.81e-05	0.00015	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—JAK2—coronary artery disease	2.81e-05	0.00015	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—IL6ST—coronary artery disease	2.8e-05	0.00015	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—SOCS1—coronary artery disease	2.8e-05	0.00015	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—S100B—coronary artery disease	2.8e-05	0.000149	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—JUNB—coronary artery disease	2.78e-05	0.000148	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—SOCS3—coronary artery disease	2.77e-05	0.000148	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PLCB1—coronary artery disease	2.77e-05	0.000148	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—HTR7—coronary artery disease	2.76e-05	0.000147	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—KITLG—coronary artery disease	2.74e-05	0.000146	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—TGFBR2—coronary artery disease	2.74e-05	0.000146	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—HTR7—coronary artery disease	2.71e-05	0.000145	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MMP3—coronary artery disease	2.67e-05	0.000143	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—STAT5A—coronary artery disease	2.67e-05	0.000143	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ITGAV—coronary artery disease	2.63e-05	0.00014	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—KNG1—coronary artery disease	2.62e-05	0.00014	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—POMC—coronary artery disease	2.61e-05	0.00014	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CREB1—coronary artery disease	2.61e-05	0.00014	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—AGTR1—coronary artery disease	2.61e-05	0.000139	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—APOB—coronary artery disease	2.58e-05	0.000138	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ITGAV—coronary artery disease	2.58e-05	0.000138	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—KNG1—coronary artery disease	2.57e-05	0.000137	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CREB1—coronary artery disease	2.56e-05	0.000137	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—POMC—coronary artery disease	2.56e-05	0.000137	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—CXCL8—coronary artery disease	2.56e-05	0.000137	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—AGTR1—coronary artery disease	2.56e-05	0.000137	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CCL2—coronary artery disease	2.56e-05	0.000137	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—JAK2—coronary artery disease	2.55e-05	0.000136	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—IL6R—coronary artery disease	2.55e-05	0.000136	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CXCL10—coronary artery disease	2.55e-05	0.000136	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—EDN1—coronary artery disease	2.54e-05	0.000136	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PLG—coronary artery disease	2.54e-05	0.000136	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CCL5—coronary artery disease	2.52e-05	0.000135	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CCL2—coronary artery disease	2.51e-05	0.000134	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—IL6R—coronary artery disease	2.5e-05	0.000134	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CXCL10—coronary artery disease	2.5e-05	0.000134	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PLG—coronary artery disease	2.49e-05	0.000133	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CSF2—coronary artery disease	2.49e-05	0.000133	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—FGF1—coronary artery disease	2.49e-05	0.000133	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ADRB2—coronary artery disease	2.47e-05	0.000132	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—LPL—coronary artery disease	2.47e-05	0.000132	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—RPS6KB1—coronary artery disease	2.45e-05	0.000131	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MEF2C—coronary artery disease	2.45e-05	0.000131	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PRKCE—coronary artery disease	2.44e-05	0.00013	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—JAK2—coronary artery disease	2.44e-05	0.00013	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—SOCS1—coronary artery disease	2.43e-05	0.00013	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—S100B—coronary artery disease	2.43e-05	0.00013	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ADRB2—coronary artery disease	2.43e-05	0.00013	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—SOCS3—coronary artery disease	2.4e-05	0.000128	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PRKCE—coronary artery disease	2.4e-05	0.000128	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—JAK2—coronary artery disease	2.39e-05	0.000128	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—SOCS1—coronary artery disease	2.39e-05	0.000128	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—S100B—coronary artery disease	2.38e-05	0.000127	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ITGB3—coronary artery disease	2.38e-05	0.000127	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—TGFBR2—coronary artery disease	2.38e-05	0.000127	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—KITLG—coronary artery disease	2.38e-05	0.000127	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—SOCS3—coronary artery disease	2.36e-05	0.000126	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—TGFBR2—coronary artery disease	2.33e-05	0.000125	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—KITLG—coronary artery disease	2.33e-05	0.000125	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CXCL8—coronary artery disease	2.33e-05	0.000124	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MMP3—coronary artery disease	2.32e-05	0.000124	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—STAT5A—coronary artery disease	2.32e-05	0.000124	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PPP2CA—coronary artery disease	2.32e-05	0.000124	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—STAT5A—coronary artery disease	2.28e-05	0.000122	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MMP3—coronary artery disease	2.28e-05	0.000122	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PRKCD—coronary artery disease	2.27e-05	0.000121	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—APOB—coronary artery disease	2.24e-05	0.00012	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—CXCL8—coronary artery disease	2.23e-05	0.000119	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—HTR2A—coronary artery disease	2.22e-05	0.000119	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—C3—coronary artery disease	2.22e-05	0.000119	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—JAK2—coronary artery disease	2.21e-05	0.000118	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—EDN1—coronary artery disease	2.21e-05	0.000118	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—APOB—coronary artery disease	2.2e-05	0.000118	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CCL5—coronary artery disease	2.19e-05	0.000117	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—CXCL8—coronary artery disease	2.18e-05	0.000117	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—JAK2—coronary artery disease	2.17e-05	0.000116	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—EDN1—coronary artery disease	2.17e-05	0.000116	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—FGF1—coronary artery disease	2.16e-05	0.000115	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CSF2—coronary artery disease	2.16e-05	0.000115	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CCL5—coronary artery disease	2.15e-05	0.000115	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—LPL—coronary artery disease	2.14e-05	0.000114	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—RPS6KB1—coronary artery disease	2.12e-05	0.000113	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MEF2C—coronary artery disease	2.12e-05	0.000113	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CSF2—coronary artery disease	2.12e-05	0.000113	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—FGF1—coronary artery disease	2.12e-05	0.000113	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—HIF1A—coronary artery disease	2.12e-05	0.000113	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—AGT—coronary artery disease	2.11e-05	0.000113	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—LPL—coronary artery disease	2.1e-05	0.000112	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MEF2C—coronary artery disease	2.09e-05	0.000111	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—RPS6KB1—coronary artery disease	2.09e-05	0.000111	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ITGB3—coronary artery disease	2.07e-05	0.000111	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—APOE—coronary artery disease	2.07e-05	0.00011	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—LEP—coronary artery disease	2.07e-05	0.00011	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—APOA1—coronary artery disease	2.04e-05	0.000109	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ITGB3—coronary artery disease	2.03e-05	0.000109	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—KDR—coronary artery disease	2.03e-05	0.000108	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CXCL8—coronary artery disease	2.02e-05	0.000108	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MAPK14—coronary artery disease	2.01e-05	0.000108	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PPP2CA—coronary artery disease	2.01e-05	0.000107	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CXCL8—coronary artery disease	1.98e-05	0.000106	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ESR1—coronary artery disease	1.97e-05	0.000105	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PRKCD—coronary artery disease	1.97e-05	0.000105	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PPP2CA—coronary artery disease	1.97e-05	0.000105	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—F2—coronary artery disease	1.95e-05	0.000104	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—FN1—coronary artery disease	1.95e-05	0.000104	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IL6ST—coronary artery disease	1.94e-05	0.000104	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PRKCD—coronary artery disease	1.94e-05	0.000104	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—C3—coronary artery disease	1.93e-05	0.000103	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—NFKBIA—coronary artery disease	1.93e-05	0.000103	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—HTR2A—coronary artery disease	1.9e-05	0.000101	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—C3—coronary artery disease	1.89e-05	0.000101	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—KIT—coronary artery disease	1.87e-05	9.97e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—HIF1A—coronary artery disease	1.84e-05	9.83e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—AGT—coronary artery disease	1.83e-05	9.79e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—HIF1A—coronary artery disease	1.81e-05	9.65e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—AGT—coronary artery disease	1.8e-05	9.61e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—APOE—coronary artery disease	1.8e-05	9.59e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—LEP—coronary artery disease	1.8e-05	9.59e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—GSK3B—coronary artery disease	1.79e-05	9.57e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—POMC—coronary artery disease	1.78e-05	9.49e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CREB1—coronary artery disease	1.78e-05	9.49e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—APOA1—coronary artery disease	1.78e-05	9.48e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—APOE—coronary artery disease	1.76e-05	9.42e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—LEP—coronary artery disease	1.76e-05	9.42e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—KDR—coronary artery disease	1.76e-05	9.4e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MAPK14—coronary artery disease	1.75e-05	9.34e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—APOA1—coronary artery disease	1.74e-05	9.31e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CCL2—coronary artery disease	1.74e-05	9.29e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IL6R—coronary artery disease	1.73e-05	9.26e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—KDR—coronary artery disease	1.73e-05	9.23e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MAPK14—coronary artery disease	1.72e-05	9.17e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ESR1—coronary artery disease	1.71e-05	9.16e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IGF1—coronary artery disease	1.71e-05	9.13e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—MAPK1—coronary artery disease	1.7e-05	9.09e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—F2—coronary artery disease	1.69e-05	9.05e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—FN1—coronary artery disease	1.69e-05	9.05e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IL6ST—coronary artery disease	1.69e-05	9.01e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ESR1—coronary artery disease	1.68e-05	8.99e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NFKBIA—coronary artery disease	1.67e-05	8.94e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—F2—coronary artery disease	1.66e-05	8.88e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—FN1—coronary artery disease	1.66e-05	8.88e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IL6ST—coronary artery disease	1.66e-05	8.85e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NFKBIA—coronary artery disease	1.64e-05	8.78e-05	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—PIK3CA—coronary artery disease	1.63e-05	8.68e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—SERPINE1—coronary artery disease	1.62e-05	8.67e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—KIT—coronary artery disease	1.62e-05	8.66e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—KIT—coronary artery disease	1.59e-05	8.5e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—FGF2—coronary artery disease	1.57e-05	8.39e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—GSK3B—coronary artery disease	1.56e-05	8.31e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—NOS3—coronary artery disease	1.55e-05	8.28e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—POMC—coronary artery disease	1.54e-05	8.24e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CREB1—coronary artery disease	1.54e-05	8.24e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	1.53e-05	8.16e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—POMC—coronary artery disease	1.52e-05	8.09e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CREB1—coronary artery disease	1.52e-05	8.09e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CCL2—coronary artery disease	1.51e-05	8.06e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—JAK2—coronary artery disease	1.51e-05	8.04e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IL6R—coronary artery disease	1.51e-05	8.04e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IGF1—coronary artery disease	1.48e-05	7.93e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CCL2—coronary artery disease	1.48e-05	7.92e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IL6R—coronary artery disease	1.48e-05	7.89e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—MAPK1—coronary artery disease	1.48e-05	7.89e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—PIK3CA—coronary artery disease	1.48e-05	7.88e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IGF1—coronary artery disease	1.46e-05	7.78e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	1.45e-05	7.75e-05	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.41e-05	7.54e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—SERPINE1—coronary artery disease	1.41e-05	7.53e-05	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	1.39e-05	7.4e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	1.38e-05	7.39e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CXCL8—coronary artery disease	1.37e-05	7.34e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—FGF2—coronary artery disease	1.36e-05	7.29e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NOS3—coronary artery disease	1.35e-05	7.19e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—FGF2—coronary artery disease	1.34e-05	7.16e-05	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	1.33e-05	7.09e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NOS3—coronary artery disease	1.32e-05	7.06e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CASP3—coronary artery disease	1.32e-05	7.03e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—JAK2—coronary artery disease	1.31e-05	6.99e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—IL6—coronary artery disease	1.31e-05	6.98e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—JAK2—coronary artery disease	1.28e-05	6.86e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.28e-05	6.85e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CCND1—coronary artery disease	1.28e-05	6.84e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	1.26e-05	6.72e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MMP9—coronary artery disease	1.24e-05	6.64e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	1.21e-05	6.44e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	1.19e-05	6.38e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	1.17e-05	6.26e-05	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	1.15e-05	6.16e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CASP3—coronary artery disease	1.14e-05	6.1e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—IL6—coronary artery disease	1.14e-05	6.06e-05	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	1.13e-05	6.05e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CASP3—coronary artery disease	1.12e-05	5.99e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	1.12e-05	5.96e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—IL6—coronary artery disease	1.11e-05	5.95e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CCND1—coronary artery disease	1.11e-05	5.94e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CCND1—coronary artery disease	1.09e-05	5.83e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MMP9—coronary artery disease	1.08e-05	5.77e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MMP9—coronary artery disease	1.06e-05	5.66e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	1.05e-05	5.59e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	1.03e-05	5.49e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	1.02e-05	5.47e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	1e-05	5.37e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	9.69e-06	5.18e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	9.52e-06	5.08e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	8.9e-06	4.75e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	8.74e-06	4.67e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	8.73e-06	4.66e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	8.72e-06	4.66e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	8.57e-06	4.58e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IL6—coronary artery disease	7.72e-06	4.12e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	7.57e-06	4.04e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	7.43e-06	3.97e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—AKT1—coronary artery disease	7.12e-06	3.8e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IL6—coronary artery disease	6.71e-06	3.58e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IL6—coronary artery disease	6.58e-06	3.52e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—AKT1—coronary artery disease	6.19e-06	3.3e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—AKT1—coronary artery disease	6.07e-06	3.24e-05	CbGpPWpGaD
